+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Home Testing Kits Market by Indication, Testing Technology, Usage Frequency, Application, Sales Channel - Global Forecast 2026-2032- Product Image
Home Testing Kits Market by Indication, Testing Technology, Usage Frequency, Application, Sales Channel - Global Forecast 2026-2032- Product Image
Sale

Home Testing Kits Market by Indication, Testing Technology, Usage Frequency, Application, Sales Channel - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532768
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Home Testing Kits Market is projected to reach USD 11.16 Billion in 2026. It is expected to continue growing at a CAGR of 8.37%, reaching USD 18.17 Billion by 2032.

Home testing kits have moved from convenience products to a core layer of decentralized healthcare. The market spans self-test and self-collection formats for pregnancy and fertility, glucose monitoring, infectious disease screening, colorectal cancer screening, genetic risk assessment, allergy and wellness panels, and medication monitoring. Demand is supported by consumer preference for privacy, faster answers, telehealth integration, and wider pharmacy and e-commerce distribution.

The strongest growth signals come from areas where at-home diagnostic testing reduces friction in care pathways: chronic disease management, preventive screening, sexual health, respiratory infection testing, and lab-connected wellness programs. COVID-19 normalized at-home sample collection and rapid antigen testing, while regulatory agencies such as the U.S. FDA, European authorities under the In Vitro Diagnostic Regulation, and national health ministries have raised expectations for clinical validation, labeling clarity, post-market surveillance, and data protection.

Transformative Shifts in the Landscape

The home testing kits landscape is shifting from single-use, product-led sales toward connected diagnostic services. Consumers increasingly expect kits to include clear digital instructions, secure result delivery, clinician access, and next-step guidance. This is encouraging partnerships between diagnostic manufacturers, CLIA-certified and accredited laboratories, telehealth providers, retail pharmacies, payers, and digital health platforms.

Regulation is also reshaping competition. The EU In Vitro Diagnostic Regulation has increased evidence and conformity requirements, while the U.S. FDA continues to scrutinize test performance, over-the-counter labeling, direct-to-consumer claims, and laboratory-developed test oversight. At the same time, retailers and employers are using home testing to support preventive care and population health programs, making reliability, logistics, consumer education, and trust as important as assay performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of home testing kits by improving the full diagnostic journey rather than replacing the test itself. AI-enabled mobile applications can support eligibility screening, adaptive instructions, image quality checks, lateral-flow test reading, symptom triage, personalized follow-up, and routing to clinical services when results require confirmation or treatment. In laboratory workflows, AI is being used to prioritize samples, flag anomalies, optimize capacity, support quality review, and improve customer support.

The cumulative impact is a shift from isolated at-home results to guided, data-rich care pathways. However, AI adoption must be anchored in clinical validation, bias testing, cybersecurity, privacy compliance, and transparent escalation to qualified professionals. For industry leaders, defensible AI in home diagnostics will depend on documented performance across diverse populations, explainable outputs, auditability, and integration with regulated quality management systems.

Key Regional Insights

North America remains one of the most advanced regions for home testing kits due to established direct-to-consumer channels, strong retail pharmacy networks, broad telehealth adoption, and FDA pathways for authorized self-tests and self-collection products. The United States anchors regional demand through extensive retail, laboratory, and digital health infrastructure, while Canada adds a public-health-oriented model with strong privacy and quality expectations.

Europe is shaped by the EU In Vitro Diagnostic Regulation, GDPR, national reimbursement structures, and high confidence in regulated preventive screening. Germany, France, Italy, Spain, and the United Kingdom show demand for home collection models that complement public health systems, especially where kits reduce clinic burden and improve screening participation. Regulatory evidence requirements and data protection rules make clinical documentation, transparent labeling, and secure result management essential across the region.

Asia-Pacific is highly diverse and fast-moving. China and India contribute scale, digital commerce, and expanding domestic diagnostic manufacturing, while Japan, South Korea, and Australia emphasize quality, aging-population needs, and regulated consumer health innovation. Latin America, led by Brazil and Mexico, is expanding through pharmacy access, private laboratories, and digital health platforms, although affordability and logistics remain key constraints. The Middle East is gaining momentum through health system modernization and digital health investment in GCC markets, while Africa presents long-term opportunity where decentralized testing can improve access in underserved communities if supported by resilient supply chains, affordability, workforce training, and public-private partnerships.

Key Group Insights

ASEAN markets are characterized by mobile-first consumers, rising private healthcare use, and uneven regulatory maturity across member states. This creates opportunity for scalable home testing models that combine multilingual instructions, e-commerce distribution, culturally adapted consumer education, and partnerships with regional laboratories, pharmacy chains, and telehealth platforms.

The GCC is investing in digital health infrastructure, preventive care, and premium healthcare access, making it attractive for connected home diagnostics, chronic disease monitoring, and wellness-oriented testing. The European Union is defined by IVDR compliance, GDPR-protected data flows, and harmonized market access expectations, which favor organizations with strong technical documentation, post-market evidence, validated supply chains, and secure digital result delivery.

BRICS countries offer scale, domestic manufacturing potential, and rising demand for affordable diagnostics, but success depends on localization, pricing discipline, regulatory navigation, and reliable distribution. G7 markets generally set high benchmarks for evidence, reimbursement alignment, quality systems, cybersecurity, and consumer protection. NATO-aligned markets, while not a health bloc, are increasingly attentive to supply chain security, domestic resilience, biosecurity, and emergency preparedness, all of which support diversified diagnostic sourcing and reliable at-home testing capacity.

Key Country Insights

The United States leads in retail access, direct-to-consumer adoption, telehealth integration, and FDA-cleared or authorized home testing pathways. Canada emphasizes regulated quality, privacy, and public-health alignment, while Mexico is expanding through pharmacy channels and private diagnostic networks. Brazil remains a major Latin American opportunity, supported by private healthcare demand, growing laboratory networks, and increasing digital health use.

In Europe, the United Kingdom has strong potential where home testing supports NHS-adjacent screening, pharmacy services, and private digital health platforms. Germany prioritizes quality, physician trust, laboratory standards, and data protection; France emphasizes regulated access and public health value; Italy and Spain show demand where home collection can improve convenience and preventive screening uptake. Russia remains a complex market shaped by localization requirements, sanctions-related supply constraints, and domestic diagnostic capacity.

China offers scale, e-commerce reach, and domestic manufacturing strength, while India presents high-volume demand for affordable self-collection, infectious disease screening, and chronic disease monitoring. Japan’s aging population supports preventive and chronic care testing, Australia benefits from regulated consumer health adoption and geographic access needs, and South Korea combines high digital readiness with advanced diagnostics manufacturing and strong consumer acceptance of technology-enabled healthcare.

Actionable Recommendations for Industry Leaders

Industry leaders should build around evidence first: clinically validated assays, clear instructions for use, robust quality systems, and post-market monitoring. Regulatory strategy should be designed early for target markets, especially where IVDR, FDA oversight, privacy law, cybersecurity requirements, or laboratory accreditation affects commercialization.

Companies should also invest in connected care models rather than standalone kits. High-performing strategies include telehealth partnerships, pharmacy distribution, secure digital result portals, multilingual user experience, AI-assisted support with validated guardrails, and payer or employer programs that demonstrate measurable improvements in screening completion, adherence, access, or timely follow-up.

Supply chain resilience is now a competitive advantage. Leaders should diversify component sourcing, validate alternate suppliers, plan cold-chain or ambient logistics where needed, strengthen specimen stability controls, and use sustainable packaging without compromising specimen integrity, accessibility, or usability.

Research Methodology

This executive summary is developed using a structured research methodology that prioritizes verified secondary sources, regulatory intelligence, and evidence triangulation. Inputs include public information from agencies and institutions such as the FDA, CDC, WHO, ECDC, EMA, national health authorities, standards bodies, clinical literature, patent databases, reimbursement documents, trade data, and publicly available regulatory records.

Findings are evaluated across product type, sample type, distribution channel, end user, regulatory pathway, technology maturity, clinical use case, and regional adoption indicators. Qualitative insights are strengthened through expert interpretation of policy shifts, diagnostic performance expectations, telehealth adoption, retail access, data privacy requirements, laboratory infrastructure, and public health priorities. Conclusions are presented only where they align with observable evidence and established industry dynamics.

Conclusion

Home testing kits are becoming a durable pillar of consumer-centered healthcare, supported by decentralized diagnostics, digital health integration, and rising demand for convenient preventive and chronic disease management. The category is no longer defined only by the test device; it is increasingly defined by trust, evidence, usability, secure data handling, result interpretation, and the quality of follow-up care.

Organizations that combine validated testing, regulatory discipline, AI-enabled guidance, strong logistics, accessible pricing, and privacy-by-design digital infrastructure will be best positioned to capture demand. As healthcare systems seek earlier detection, lower care burden, and broader access, home testing kits will continue to expand from episodic use into integrated, longitudinal health management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Home Testing Kits Market, by Indication
7.1. Chronic Disease Testing
7.1.1. Cholesterol Home Test Kits
7.1.1.1. Adult
7.1.1.2. Elderly
7.1.2. Blood Glucose Monitoring Kits
7.1.2.1. Pediatric
7.1.2.2. Adult
7.1.2.3. Elderly
7.1.3. HbA1c Test Kits
7.1.3.1. Pediatric
7.1.3.2. Adult
7.1.3.3. Elderly
7.1.4. Kidney Function Test Kits
7.1.4.1. Blood Kidney Function Test Kits
7.1.4.1.1. Pediatric
7.1.4.1.2. Adult
7.1.4.1.3. Elderly
7.1.4.2. Urine Kidney Function Test Kits
7.1.4.2.1. Pediatric
7.1.4.2.2. Adult
7.1.4.2.3. Elderly
7.1.5. Coagulation Monitoring Test Kits
7.1.5.1. Pediatric
7.1.5.2. Adult
7.1.5.3. Elderly
7.2. Infectious Disease Testing
7.2.1. COVID Rapid Antigen Test Kits
7.2.1.1. Saliva COVID Rapid Antigen Test Kits
7.2.1.1.1. Pediatric
7.2.1.1.2. Adult
7.2.1.1.3. Elderly
7.2.1.2. Swab COVID Rapid Antigen Test Kits
7.2.1.2.1. Pediatric
7.2.1.2.2. Adult
7.2.1.2.3. Elderly
7.2.2. Hepatitis Home Test Kits
7.2.2.1. Blood Hepatitis Home Test Kits
7.2.2.1.1. Pediatric
7.2.2.1.2. Adult
7.2.2.1.3. Elderly
7.2.2.2. Saliva Hepatitis Home Test Kits
7.2.2.2.1. Pediatric
7.2.2.2.2. Adult
7.2.2.2.3. Elderly
7.2.3. Sexually Transmitted Infections (STIs) Test Kits
7.2.3.1. Blood Sexually Transmitted Infections (STIs) Test Kits
7.2.3.1.1. Pediatric
7.2.3.1.2. Adult
7.2.3.1.3. Elderly
7.2.3.2. Urine Sexually Transmitted Infections (STIs) Test Kits
7.2.3.2.1. Pediatric
7.2.3.2.2. Adult
7.2.3.2.3. Elderly
7.2.3.3. Swab Sexually Transmitted Infections (STIs) Test Kits
7.2.3.3.1. Pediatric
7.2.3.3.2. Adult
7.2.3.3.3. Elderly
7.2.4. Gastrointestinal Infections Test Kits
7.2.4.1. Blood Gastrointestinal Infections Test Kits
7.2.4.1.1. Adult
7.2.4.1.2. Elderly
7.2.4.2. Stool Gastrointestinal Infections Test Kits
7.2.4.2.1. Pediatric
7.2.4.2.2. Adult
7.2.4.2.3. Elderly
7.3. Reproductive Health Kits
7.3.1. Pregnancy Test Kits
7.3.1.1. Pediatric
7.3.1.2. Adult
7.3.1.3. Elderly
7.3.2. Ovulation (LH) Test Kits
7.3.3. Menopause Tests Kits
7.3.3.1. Urine
7.3.3.2. Saliva
7.4. Hormone & Wellness Tets Kits
7.4.1. Thyroid Function Test Kits
7.4.1.1. Pediatric
7.4.1.2. Adult
7.4.1.3. Elderly
7.4.2. Vitamin D Test Kits
7.4.2.1. Pediatric
7.4.2.2. Adult
7.4.2.3. Elderly
7.5. Substance & Toxicology Testing
7.5.1. Drug Testing Kits
7.5.1.1. Urine Drug Testing Kits
7.5.1.1.1. Pediatric
7.5.1.1.2. Adult
7.5.1.1.3. Elderly
7.5.1.2. Saliva Drug Testing Kits
7.5.1.2.1. Pediatric
7.5.1.2.2. Adult
7.5.1.2.3. Elderly
7.5.1.3. Blood Drug Testing Kits
7.5.1.3.1. Pediatric
7.5.1.3.2. Adult
7.5.1.3.3. Elderly
7.5.2. Alcohol Tests Kits
7.5.2.1. Blood Alcohol Tests Kits
7.5.2.1.1. Pediatric
7.5.2.1.2. Adult
7.5.2.1.3. Elderly
7.5.2.2. Urine Alcohol Tests Kits
7.5.2.2.1. Pediatric
7.5.2.2.2. Adult
7.5.2.2.3. Elderly
7.5.2.3. Saliva Alcohol Tests Kits
7.5.2.3.1. Pediatric
7.5.2.3.2. Adult
7.5.2.3.3. Elderly
8. Home Testing Kits Market, by Testing Technology
8.1. Immunoassay
8.2. Molecular Diagnostics
8.2.1. PCR & RT-PCR
8.2.2. CRISPR-Based Detection
8.3. Microfluidic Lab-On-Chip
8.4. Chemical & Chromatographic
8.5. Biosensors
9. Home Testing Kits Market, by Usage Frequency
9.1. One Time Use
9.2. Recurring Use
10. Home Testing Kits Market, by Application
10.1. Disease Monitoring
10.2. Lifestyle Monitoring
10.2.1. Fitness Tracking
10.2.2. Nutritional Assessments
10.3. Preventive Health
11. Home Testing Kits Market, by Sales Channel
11.1. Offline
11.1.1. Pharmacy Retail
11.1.2. General Retail
11.2. Online
11.2.1. Company Websites
11.2.2. E-Commerce Platforms
12. Asia-Pacific Home Testing Kits Market
13. Europe Home Testing Kits Market
14. North America Home Testing Kits Market
15. Latin America Home Testing Kits Market
16. Middle East Home Testing Kits Market
17. Africa Home Testing Kits Market
18. NATO Home Testing Kits Market
19. G7 Home Testing Kits Market
20. European Union Home Testing Kits Market
21. BRICS Home Testing Kits Market
22. ASEAN Home Testing Kits Market
23. GCC Home Testing Kits Market
24. United States Home Testing Kits Market
25. China Home Testing Kits Market
26. Germany Home Testing Kits Market
27. Japan Home Testing Kits Market
28. India Home Testing Kits Market
29. United Kingdom Home Testing Kits Market
30. France Home Testing Kits Market
31. South Korea Home Testing Kits Market
32. Canada Home Testing Kits Market
33. Italy Home Testing Kits Market
34. Brazil Home Testing Kits Market
35. Australia Home Testing Kits Market
36. Spain Home Testing Kits Market
37. Russia Home Testing Kits Market
38. Mexico Home Testing Kits Market
39. Japan Home Testing Kits Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. F. Hoffmann-La Roche Ltd
41.3. Exact Sciences Corporation
41.4. LifeScan Enterprises LLC
41.5. Becton, Dickinson and Company
41.6. QuidelOrtho Corporation
41.7. Ascensia Diabetes Care Holdings AG
41.8. McKesson Corporation
41.9. Medline Industries, LP
41.10. Sinocare Inc
41.11. Terumo Corporation
41.12. OraSure Technologies Inc.
41.13. Arkray, Inc.
41.14. Eurofins Scientific Limited
41.15. Bionime Corporation
41.16. Biosynex SA
41.17. BTNX Inc.
41.18. TaiDoc Technology Corporation
41.19. VivaChek Biotech (Hangzhou) Co., Ltd.
41.20. BioLytical Laboratories Inc.
41.21. i-SENS, Inc.
41.22. J. Mitra & Co. Pvt. Ltd.
41.23. Prima Lab SA
41.24. AdvaCare Pharma USA
41.25. Atlas Laboratories Ltd
41.26. Atlas Medical GmbH
41.27. Atomo diagnostics
41.28. InTec PRODUCTS, INC.
41.29. Nureca Limited
41.30. SelfDiagnostics OU
41.31. Vitruvian Health
List of Figures
FIGURE 1. GLOBAL HOME TESTING KITS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HOME TESTING KITS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HOME TESTING KITS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HOME TESTING KITS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HOME TESTING KITS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HOME TESTING KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HOME TESTING KITS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL HOME TESTING KITS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL HOME TESTING KITS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HOME TESTING KITS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HOME TESTING KITS MARKET SIZE, BY TESTING TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HOME TESTING KITS MARKET SIZE, BY TESTING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HOME TESTING KITS MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HOME TESTING KITS MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HOME TESTING KITS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HOME TESTING KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HOME TESTING KITS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL HOME TESTING KITS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CHINA HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. JAPAN HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. INDIA HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. CANADA HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. BRAZIL HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. AUSTRALIA HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. SPAIN HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. RUSSIA HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. JAPAN HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 65. JAPAN HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HOME TESTING KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HOME TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HOME TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HOME TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HOME TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HOME TESTING KITS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL HOME TESTING KITS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL HOME TESTING KITS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CHOLESTEROL HOME TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CHOLESTEROL HOME TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CHOLESTEROL HOME TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HBA1C TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HBA1C TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HBA1C TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL KIDNEY FUNCTION TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL KIDNEY FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL KIDNEY FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD KIDNEY FUNCTION TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD KIDNEY FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD KIDNEY FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL URINE KIDNEY FUNCTION TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL URINE KIDNEY FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL URINE KIDNEY FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COAGULATION MONITORING TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COAGULATION MONITORING TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COAGULATION MONITORING TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SALIVA COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SALIVA COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SALIVA COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL SWAB COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL SWAB COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL SWAB COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL HEPATITIS HOME TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL HEPATITIS HOME TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL HEPATITIS HOME TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BLOOD HEPATITIS HOME TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BLOOD HEPATITIS HOME TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BLOOD HEPATITIS HOME TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL SALIVA HEPATITIS HOME TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL SALIVA HEPATITIS HOME TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL SALIVA HEPATITIS HOME TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BLOOD SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BLOOD SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BLOOD SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL URINE SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL URINE SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL URINE SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL SWAB SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL SWAB SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL SWAB SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BLOOD GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BLOOD GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BLOOD GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL STOOL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL STOOL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL STOOL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL REPRODUCTIVE HEALTH KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL REPRODUCTIVE HEALTH KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL REPRODUCTIVE HEALTH KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL PREGNANCY TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL PREGNANCY TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL PREGNANCY TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL OVULATION (LH) TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL OVULATION (LH) TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL OVULATION (LH) TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL MENOPAUSE TESTS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL MENOPAUSE TESTS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL MENOPAUSE TESTS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL HORMONE & WELLNESS TETS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL HORMONE & WELLNESS TETS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL HORMONE & WELLNESS TETS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL THYROID FUNCTION TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL THYROID FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL THYROID FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL VITAMIN D TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL VITAMIN D TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL VITAMIN D TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL SUBSTANCE & TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL SUBSTANCE & TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL SUBSTANCE & TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL DRUG TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL DRUG TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL URINE DRUG TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL URINE DRUG TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL URINE DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL SALIVA DRUG TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 277. GLOBAL SALIVA DRUG TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL SALIVA DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 280. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 281. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 283. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 284. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 286. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 287. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 288. GLOBAL BLOOD DRUG TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 289. GLOBAL BLOOD DRUG TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 290. GLOBAL BLOOD DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 292. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 293. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 295. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 296. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 297. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 298. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 299. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 301. GLOBAL ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 302. GLOBAL ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. GLOBAL BLOOD ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 304. GLOBAL BLOOD ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 305. GLOBAL BLOOD ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 306. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 307. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 308. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 309. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 310. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 311. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 312. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 313. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 314. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 315. GLOBAL URINE ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 316. GLOBAL URINE ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 317. GLOBAL URINE ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 318. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 319. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 320. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 321. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 322. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 323. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 324. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 325. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 326. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 327. GLOBAL SALIVA ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 328. GLOBAL SALIVA ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 329. GLOBAL SALIVA ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 330. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 331. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 332. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 333. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 334. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 335. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 336. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 337. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 338. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 339. GLOBAL HOME TESTING KITS MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 340. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 341. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 342. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 343. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 344. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 345. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 346. GLOBAL PCR & RT-PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 347. GLOBAL PCR & RT-PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 348. GLOBAL PCR & RT-PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 349. GLOBAL CRISPR-BASED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 350. GLOBAL CRISPR-BASED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 351. GLOBAL CRISPR-BASED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 352. GLOBAL MICROFLUIDIC LAB-ON-CHIP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 353. GLOBAL MICROFLUIDIC LAB-ON-CHIP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 354. GLOBAL MICROFLUIDIC LAB-ON-CHIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 355. GLOBAL CHEMICAL & CHROMATOGRAPHIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 356. GLOBAL CHEMICAL & CHROMATOGRAPHIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 357. GLOBAL CHEMICAL & CHROMATOGRAPHIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 358. GLOBAL BIOSENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 359. GLOBAL BIOSENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 360. GLOBAL BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 361. GLOBAL HOME TESTING KITS MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 362. GLOBAL ONE TIME USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 363. GLOBAL ONE TIME USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 364. GLOBAL ONE TIME USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 365. GLOBAL RECURRING USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 366. GLOBAL RECURRING USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 367. GLOBAL RECURRING USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 368. GLOBAL HOME TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 369. GLOBAL DISEASE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 370. GLOBAL DISEASE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 371. GLOBAL DISEASE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 372. GLOBAL LIFESTYLE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 373. GLOBAL LIFESTYLE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 374. GLOBAL LIFESTYLE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 375. GLOBAL FITNESS TRACKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 376. GLOBAL FITNESS TRACKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 377. GLOBAL FITNESS TRACKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 378. GLOBAL NUTRITIONAL ASSESSMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 379. GLOBAL NUTRITIONAL ASSESSMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 380. GLOBAL NUTRITIONAL ASSESSMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 381. GLOBAL PREVENTIVE HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 382. GLOBAL PREVENTIVE HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 383. GLOBAL PREVENTIVE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 384. GLOBAL HOME TESTING KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 385. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 386. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 387. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 388. GLOBAL PHARMACY RETAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 389. GLOBAL PHARMACY RETAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 390. GLOBAL PHARMACY RETAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 391. GLOBAL GENERAL RETAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 392. GLOBAL GENERAL RETAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 393. GLOBAL GENERAL RETAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 394. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 395. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 396. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 397. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 398. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 399. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 400. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 401. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLIO

Companies Mentioned

The companies featured in this Home Testing Kits market report include:
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Exact Sciences Corporation
  • LifeScan Enterprises LLC
  • Becton, Dickinson and Company
  • QuidelOrtho Corporation
  • Ascensia Diabetes Care Holdings AG
  • McKesson Corporation
  • Medline Industries, LP
  • Sinocare Inc
  • Terumo Corporation
  • OraSure Technologies Inc.
  • Arkray, Inc.
  • Eurofins Scientific Limited
  • Bionime Corporation
  • Biosynex SA
  • BTNX Inc.
  • TaiDoc Technology Corporation
  • VivaChek Biotech (Hangzhou) Co., Ltd.
  • BioLytical Laboratories Inc.
  • i-SENS, Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Prima Lab SA
  • AdvaCare Pharma USA
  • Atlas Laboratories Ltd
  • Atlas Medical GmbH
  • Atomo diagnostics
  • InTec PRODUCTS, INC.
  • Nureca Limited
  • SelfDiagnostics OU
  • Vitruvian Health

Table Information

Report AttributeDetails
No. of Pages181
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.16 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.17 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Direct-to-Consumer Testing Industry: Global Markets 2024-2029 - Product Image

Direct-to-Consumer Testing Industry: Global Markets 2024-2029

  • Report
  • 81 Pages
  • Global
From
Self-Testing Market - Global Strategic Business Report - Product Image

Self-Testing Market - Global Strategic Business Report

  • Report
  • 198 Pages
  • Global
From
Home Testing & Home Healthcare Market by Offering, Sample Type, Testing Modality, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032 - Product Image

Home Testing & Home Healthcare Market by Offering, Sample Type, Testing Modality, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Paternity Test Home Kit Market by Test Type, Technology, Sample Type, Distribution Channel, Application, End User - Global Forecast 2026-2032 - Product Image

Paternity Test Home Kit Market by Test Type, Technology, Sample Type, Distribution Channel, Application, End User - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Home Care Testing - Global Strategic Business Report - Product Image

Home Care Testing - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.